SCHEMBL12420946

SCHEMBL12420946

CCC(c1ccccc1)n1cnc2ccc(NC(=O)c3cccc(NC(=N)N)c3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.44
NPC1 O15118 3/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
RAB9A P51151 2/20 0.41
ACSS2 Q9NR19 1/20 0.41
F10 P00742 3/20 0.40
F9 P00740 1/20 0.40
KCNK3 O14649 1/20 0.40
KCNK9 Q9NPC2 1/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 2/20 0.39
PLAU P00749 2/20 0.39
MAPT P10636 1/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
F2 P00734 2/20 0.39
PRSS1 P07477 2/20 0.39
ORAI1 Q96D31 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12419733 0.93 NPC1 (0.48) KHKNPC1KMT2AMEN1RAB9A
SCHEMBL12420209 0.93 F10 (0.44) KHKNPC1RAB9AACSS2F10
SCHEMBL2296401 0.91 ITGB3 (0.45) KHKNPC1KMT2AMEN1RAB9A
SCHEMBL12420304 0.90 KHK (0.39) KHKNPC1KMT2AMEN1RAB9A
SCHEMBL2297316 0.89 NPC1 (0.43) KHKNPC1KMT2AMEN1RAB9A
SCHEMBL12420296 0.85 NPC1 (0.49) NPC1KMT2AMEN1RAB9AF10
SCHEMBL2296240 0.84 NPC1 (0.46) KHKNPC1KMT2AMEN1RAB9A
SCHEMBL2300721 0.84 F10 (0.44) NPC1KMT2AMEN1RAB9AF10
SCHEMBL2299091 0.82 NPC1 (0.44) KHKNPC1KMT2AMEN1RAB9A
SCHEMBL12420302 0.82 NPC1 (0.44) KHKNPC1KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed